Table of Contents
About This Report Pharma faces a number of key resistors to growth including the impending 2011 patent cliff which is set to erode USD 78 billion in global branded sales from drugs facing patent expiry over the 201014 period (plus USD 32 billion from continued erosion of already expired brands). Price cuts, reimbursement restrictions and growing regulatory pressure are further set to limit sales growth going forward. What...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Shadi
+1 718 618 4897
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use ...
Product Synopsis Disease-related, demographic, and desire-led drivers are making health of growing importance to food marketers. However, barriers such as cost, habits, and confusion over how to eat healthily ...
STUDY OBJECTIVES A drug delivery system is one of the very important aspects in today's growth in the pharmaceutical industry. BCC Research's goal in steering this study is to provide an overview of the ...
... liver biopsy (currently only definitive test to confirm nash diagnosis and stage disease) simple steatosis nash liver prognosis good treat cardiac risks treat associated conditions pcps ...
... New congenital heart disease review what matters a commitment to research ensures that services are continually focussed on improvement and development, so networks will be required to have ...
Reportlinker.com © Copyright 2014. All rights reserved.